Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis.

International journal of mycobacteriology - 1 Jan 2000

Qamar Salima, Farooqi Joveria Q, Jabeen Kausar, Hasan Rumina

Abstract excerpt

BACKGROUND: Tuberculosis is one of the most prevalent diseases in Pakistan. Pakistan has the highest burden of MDR-TB in the Eastern Mediterranean region. Ethionamide is an anti-tuberculous drug frequently used to treat MDR-TB. Its drug susceptibility testing is not easily available in resource limited settings. Since it acts on the same target protein as isoniazid (inhA protein encoded by inhA gene), we sought...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoniazid

Share to Mycobacterium tuberculosis

Share to Pakistan

Share to Phenotype

Source

Identifiers

PMID: 28559519
DOI: 10.4103/ijmy.ijmy_34_17

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis.PMID 28559519Read ↗

Isoniazid-resistant tuberculosis: a cause for concern?Semantic proximity Read ↗

Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.Semantic proximity Read ↗

Can inhA mutation predict ethionamide resistance?Semantic proximity Read ↗

Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimensSemantic proximity Read ↗

High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.Semantic proximity Read ↗

Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.Semantic proximity Read ↗

Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.Semantic proximity Read ↗

Effects of mutations in multiple Ethionamide-resistance-associated genes among Mycobacterium tuberculosis clinical isolates from China.Semantic proximity Read ↗

Tuberculosis and Its Predictors in Pakistani Population Transmission Dynamics and Drug Resistance of MycobacteriumSemantic proximity Read ↗

A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.Semantic proximity Read ↗

Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.Semantic proximity Read ↗

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.